In a world increasingly shaped by scientific breakthroughs in healthcare, Kenyan-born researcher Clara Jebet Sei, MPH., DrPH(c) is emerging as a powerful force in the global fight against infectious diseases. With over two decades of experience in the biopharmaceutical industry, Clara is making remarkable strides in vaccine and antibody development—positioning herself among the leading Kenyan diaspora professionals transforming global public health.
A Distinguished Career in the Development of Vaccines and Therapeutics
Currently serving as Vice President of Vaccine and Antibody Development and Chief Technology Transfer Officer at at Longhorn Vaccines and Diagnostics LLC, Clara Jebet Sei plays a critical leadership role in advancing cutting-edge biomedical solutions. Her work spans both the United States and international scientific collaborations, focusing on the diagnosis, prevention, treatment, and control of infectious diseases.
With more than 20 years of experience in basic research and clinical development, Clara has built a reputation for excellence in vaccine innovation and therapeutic discovery. Her expertise covers a wide range of disciplines, including:
- Vaccine and antibody development
- Drug discovery and clinical program strategy
- Regulatory compliance and study design
- Biotechnology research and quality control
- Laboratory establishment and operational management
- Global public health
- Executive leadership / management
Her leadership continues to drive impactful scientific programs that are shaping the future of global health.
Driving Innovation Through Global Scientific Collaboration
Clara’s role extends beyond laboratory research. She is instrumental in managing high-level collaborations between government agencies, academic institutions, military institutions and private sector organizations. Her experience includes overseeing critical agreements such as:
- NDAs (Non-Disclosure Agreements)
- MTAs (Material Transfer Agreements)
- CRADAs (Cooperative Research and Development Agreements)
Through these partnerships, Clara ensures that innovative research moves efficiently from concept to real-world application—bridging the gap between science and societal impact.
Her ability to coordinate diverse teams of world-class researchers has led to the successful execution of multiple global projects aimed at improving diagnostics, vaccines, and immunologic therapeutics.
A Champion for Global Public Health
Clara Jebet Sei’s work is deeply rooted in a passion for global public health advancement. At Longhorn, she leads efforts to implement new molecular tools that enhance disease detection and accelerate the development of safer, more effective vaccines and therapeutics.
Her contributions are particularly significant in a post-pandemic world where the demand for innovative healthcare and global public health solutions continues to grow. By strengthening vaccine development pipelines and improving immunotherapy approaches, Clara is helping to safeguard communities worldwide.
Inspiring the Kenyan Diaspora and Future Scientists
Clara’s journey stands as a powerful inspiration to young Kenyans and diaspora professionals pursuing careers in science, technology, engineering, and medicine (STEM). Her success highlights the immense potential of Kenyan talent on the global stage.
From her scientific leadership to her contributions in innovation and research, Clara represents a growing number of Kenyan diaspora experts making a meaningful impact in global industries.
As the world continues to rely on science to combat emerging health threats, professionals like Clara Jebet Sei are not only advancing medicine but also elevating Kenya’s presence in global scientific leadership. Her contributions reflect the pride and impact of Kenyan-American leadership, inspiring the next generation of scientists and public health professionals across both nations.
 is emerging){kind=link}